News | May 15, 2015

Accreditation for Cardiovascular Excellence Publishes New Standards for Electrophysiology and ICDs

Evidence-based guidelines offer comprehensive review of interventional procedures for heart rhythm disorders

Accreditation for Cardiovascular Excellence, standards, EP, ICDs, guidelines

May 15, 2015 — Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

"The ACE Standards for Electrophysiology (EP) and Implantable Cardioverter Defibrillators (ICD) Accreditation will allow EP laboratories to evaluate themselves against other facilities performing similar procedures and have input from an unbiased body of experts to help promote quality improvement within their center," said Michael S. Katcher, M.D., FHRS, director of cardiac electrophysiology and pacing, North Shore Medical Center. "These standards meet the needs of the EP laboratory, because they include diagnostic and therapeutic procedures and the core functions of EP labs."

Prior to the development of the ACE standards, however, no broad based performance guidance had been published for quality care in the EP and ICD settings. The new ACE Standards define the current evidence-based best practices for a variety of diagnostic and interventional procedures and device implantation.

The ACE EP and ICD Standards will be launched at the ACE exhibit at the 2015 Heart Rhythm Society 2015 (HRS 2015) meeting, May 13-16, in Boston. 

For more information: www.cvexcel.org


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
Subscribe Now